Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
6
100%

Phase Distribution

0

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
6(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 26 (100.0%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_2

Effects of Exercise Training and AGE-crosslink Breaker on Cardiovascular Structure and Function

NCT01417663
completedphase_2

The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

NCT00045981
completedphase_2

The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure

NCT00516646
completedphase_2

The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure

NCT00043836
completedphase_2

The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling

NCT00045994
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01417663Phase 2

Effects of Exercise Training and AGE-crosslink Breaker on Cardiovascular Structure and Function

Completed
NCT00045981Phase 2

The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

Completed
NCT00516646Phase 2

The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure

Completed
NCT00043836Phase 2

The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure

Completed
NCT00045994Phase 2

The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling

Completed
NCT00739687Phase 2

Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6